Great opening for the UCL Cancer Domain symposium with Charles Swanton. Charlie took us on a cancer evolution journey through 10 years of TRACERx study UCL Cancer Institute The Crick Science and Innovation at Cancer Research UK CRUKCOLcentre Mariam Jamal-Hanjani Nnennaya Kanu Nicholas McGranahan Quezada Lab
precisionmedicineonline.com/molecular-diag…
TRACERx is only one data point but suggests that the superior sensitivity, lower limit of detection & better prediction of clinical outcomes make $PSNL NeXT Personal a more effective tool for guiding treatment decisions compared to $NTRA & $NVTA.
Exciting that Charles Swanton of Cancer Research UK had the opportunity to meet the King and Queen and tell them about the TRACERx study, which is contributing groundbreaking insights into our understanding of #lungcancer ! #LCSM
During the visit, our chief clinician, Charles Swanton, highlighted some of the innovative research that Cancer Research UK is supporting at the hospital, including our single biggest investment in lung cancer research, TRACERx.
It’s been lovely to hear how much the visit meant to patients…
The Royal Family UCLH Macmillan Cancer Support several legends in this video (i mean #TRACERx folks obv!)